Shimizuguchi et al. Hepatoma Res 2020;6:66 I http://dx.doi.org/10.20517/2394-5079.2020.51 Page 5 of 10 Figure 1. Local control rate (top), progression-free survival rate (middle), and overall survival rate (bottom) for all patients in this study